Physician profile
Ngoc Pham
NPI 1912342908
$1,795.74
in general payments reported to CMS, 2019-2025
18 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.90 · 2020: $135 · 2021: $12.73 · 2022: $155 · 2023: $482 · 2024: $450 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,411.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $456.79 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Astrazeneca Pharmaceuticals LP | $352.08 | 2019-2025 | Fasenra, Imfinzi |
| Gilead Sciences, INC. | $221.75 | 2020-2024 | |
| Siemens Medical Solutions USA, INC. | $163.28 | 2023 | Truebeam |
| Tempus Ai, INC | $151.14 | 2024-2025 | Xt Cdx |
| Blue Earth Diagnostics | $101.53 | 2025 | Posluma |
| Novartis Pharmaceuticals Corporation | $62.41 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $55.83 | 2025 | |
| Sumitomo Pharma America, INC. | $45.45 | 2023 | Orgovyx |
| Novocure INC. | $42.93 | 2024-2025 | Optune Gio, Optune |
| Agios Pharmaceuticals, INC. | $26.09 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.56 | 2025 | |
| Innovation Technologies INC | $19.58 | 2025 | Irrisept |
| Daiichi Sankyo INC. | $19.33 | 2024 | Injectafer |
| Amgen INC. | $18.57 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.00 | 2022 | |
| Janssen Biotech, INC. | $12.73 | 2021 | |
| Cashflow Solutions, LLC | $11.69 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ngoc Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.